Protein C News and Research

RSS

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

According to the World Health Organization, each year there are an estimated 1 billion cases of influenza, between 3-5 million severe cases and up to 650,000 influenza-related respiratory deaths globally.

25 Jan 2023

New interactive tool helps to calculate risk of developing advanced breast cancer

Breast cancer is now the leading cause of global cancer incidence among women but determining who will develop breast cancer is still a challenge for the medical community.

25 Jan 2023

Scientists reveal how genetic changes lead to differences in the size of cancer cells

Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.

25 Jan 2023

Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

Researchers described the coronavirus disease 2019 (COVID-19) prevention network (CoVPN) and its contribution to clinical efficacy evaluations of COVID-19 vaccines in phase 3 trials.

25 Jan 2023

Few simple adjustments to your daily diet can help reduce heart disease risk

Heart disease is the leading cause of death in the United States for both men and women, with half of all Americans (47%) qualifying for at least one of the three key risk factors (high blood pressure, high cholesterol, smoking cigarettes).

25 Jan 2023

Process analytical technologies and monitoring inline R&D biopharma processes with Raman spectroscopy

Established in 2004, process analytical technology (PAT), a quality assurance program for the pharmaceutical industry developed by the US Food and Drug Administration, enables pharmaceutical manufacturers to control critical process parameters (CPPs).

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 25 Jan 2023

Breathing and tilting motions of influenza glycoproteins could be exploited to better defend against flu

The potential "tripledemic" of influenza, SARS-CoV-2 and RSV (respiratory syncytial virus) infection continues to be a concern.

25 Jan 2023

FDA briefing discusses different COVID-19 vaccination regimens

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory committee meeting scheduled for January 26, 2023, the national agency proposed that people should be given yearly coronavirus disease 2019 (COVID-19) vaccines.

25 Jan 2023

Study shows cutaneous touch neuronal cells to be critical for sexual receptiveness

Researchers studied the social relevance of G protein-coupled receptor (GPCR) Mrgprb4-lineage touch neurons in sexual touch and receptivity.

25 Jan 2023

E-cigarette aerosols can cause cellular and molecular changes in the lungs

New research published in The FASEB Journal indicates that e-cigarettes can cause cellular and molecular changes in the lungs.

25 Jan 2023

Study suggests cortical hemorrhage in fetal brain may be associated with COVID-19

Researchers evaluated the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on fetal brain health.

25 Jan 2023

Single drop of blood can be used to measure thousands of molecules

Researchers at Stanford Medicine have shown they can measure thousands of molecules — some of which are signals of health — from a single drop of blood.

25 Jan 2023

Cryo-electron microscopy reveals detailed blueprint of viral genome replication machinery

RNA viruses, such as the coronavirus that causes COVID-19, are in a life-and-death race the moment they infect a cell.

25 Jan 2023

Targeting newly discovered signaling pathway could boost the potency of cancer therapeutics

Cells zealously protect the integrity of their genomes, because damage can lead to cancer or cell death. The genome - a cell's complete set of DNA - is most vulnerable while it is being duplicated before a cell divides. Cancer cells constantly are dividing, so their genomes are constantly in jeopardy.

24 Jan 2023

Mosaic RBD nanoparticles offer 100% protection against SARS-CoV-2 in animal model

A recent PNAS journal study has sought to address the above-stated drawback and developed a new strategy that involves a self-assembling scaffold of proliferating cell nuclear antigen (PCNA). This technique can develop nanoparticles containing evenly incorporated heterotypic antigens.

24 Jan 2023

Protein C News and Research

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

New interactive tool helps to calculate risk of developing advanced breast cancer

Scientists reveal how genetic changes lead to differences in the size of cancer cells

Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

Few simple adjustments to your daily diet can help reduce heart disease risk

Process analytical technologies and monitoring inline R&D biopharma processes with Raman spectroscopy

Breathing and tilting motions of influenza glycoproteins could be exploited to better defend against flu

FDA briefing discusses different COVID-19 vaccination regimens

Study shows cutaneous touch neuronal cells to be critical for sexual receptiveness

E-cigarette aerosols can cause cellular and molecular changes in the lungs

Study suggests cortical hemorrhage in fetal brain may be associated with COVID-19

Single drop of blood can be used to measure thousands of molecules

Cryo-electron microscopy reveals detailed blueprint of viral genome replication machinery

Targeting newly discovered signaling pathway could boost the potency of cancer therapeutics

Mosaic RBD nanoparticles offer 100% protection against SARS-CoV-2 in animal model

Researchers use multiplexed 3D imaging to perform molecular and morphological assessments of colorectal cancers

Study reveals sex differences in response to drugs targeting tauopathies

Study shows spatial organization in tumor cells

Study provides an estimate of people in the United States with VEXAS syndrome

Study uncovers protein that acts as a brake for DNA replication

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News